Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT)

Clinical trial NCT07286747 · RECRUITING

Trial details

NCT number: NCT07286747
Sponsor: University Hospital Schleswig-Holstein
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)

Start date: 2026-03-03
Primary completion: 2028-05-01
Enrollment: 390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.